Bausch Health Completes Acquisition of DURECT Corporation, Expanding Late-stage Liver Disease Portfolio 11 September
Bausch Health to Acquire DURECT Corporation, Strengthening Commitment to Developing Innovative Solutions for Patients with Liver Disease 29 July
medical device investing Bausch Health Responds to Rumors of a Potential Sale of Bausch + Lomb 12 December 2024
